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Abstract: The bacterium Paenibacillus larvae is the causative agent of American foulbrood, the most
devastating bacterial disease of honeybees. Because P. larvae is antibiotic resistant, phages that infect
it are currently used as alternative treatments. However, the acquisition by P. larvae of CRISPR spacer
sequences from the phages could be an obstacle to treatment efforts. We searched nine complete
genomes of P. larvae strains and identified 714 CRISPR spacer sequences, of which 384 are unique.
Of the four epidemiologically important P. larvae strains, three of these have fewer than 20 spacers,
while one strain has over 150 spacers. Of the 384 unique spacers, 18 are found as protospacers
in the genomes of 49 currently sequenced P. larvae phages. One P. larvae strain does not have any
protospacers found in phages, while another has eight. Protospacer distribution in the phages is
uneven, with two phages having up to four protospacers, while a third of phages have none. Some
phages lack protospacers found in closely related phages due to point mutations, indicating a possible
escape mechanism. This study serve a point of reference for future studies on the CRISPR-Cas system
in P. larvae as well as for comparative studies of other phage–host systems.
Keywords: American foulbrood; Paenibacillus larvae; CRISPR; spacers; protospacers; phages;
bacterial immunity
1. Introduction
American foulbrood (AFB) is the most destructive bacterial disease in honeybees
(Apis mellifera) [1]. It is caused by the Gram-positive, spore-forming bacterium Paenibacil-
lus larvae and afflicts honeybee larvae. AFB outbreaks usually occur when larvae ingest
food contaminated with P. larvae spores; as few as ten spores are enough to trigger a fatal
infection [1,2]. The P. larvae spores germinate and rapidly proliferate in the larval midgut,
lysing the infected larva from the inside within 12 h of ingestion [1,3]. As worker bees
remove the deceased larvae, they inadvertently spread millions of spores through the
hive [1,4], with the result being complete hive collapse on the order of 7–12 days [1,5].
P. larvae is classified into five genotypes based on enterobacterial repetitive intergenic con-
sensus (ERIC) primers; the genotypes correlate with phenotypic differences [6]. The ERIC I
and ERIC II genotypes are found worldwide and cause virtually all AFB outbreaks [1,6],
with ERIC I accounting for the majority [6]. The ERIC III and ERIC IV strains are closely
related genetically, but have not been isolated in the field for decades, while ERIC V was
isolated from a field honey sample in 2020 [6]. Traditionally, AFB has been treated using
antibiotics (tylosin, lincomycin, and oxytetracycline), but antibiotic resistant strains of
P. larvae are now widespread [1,6–9]. Additionally, antibiotic residues are found in honey
after antibiotic treatments [7], and thus several countries have banned the use of antibiotics
to treat AFB [5]. P. larvae spores are extremely durable, being resistant to heat and cold,
and can remain infectious for decades [1,10]. If an infection is not treatable with antibiotics,
total incineration of the hive and any beekeeping equipment is required [1].
The problems associated with antibiotic treatment of AFB have led to interest in phage
therapy as an alternative treatment. Three studies have shown that phages are effective
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at lysing P. larvae in laboratory settings [11–13]; in one of these studies, a lysis screen that
tested the ability of 29 phages to lyse 11 P. larvae strains showed that there is considerable
variability in lytic ability and host range between phages [13]. Additionally, one field study
has successfully used phages to treat AFB in the field [14]. The first P. larvae phage genome
was sequenced in 2013 [15], and the current number of sequenced phage genomes currently
stands at 49 [11,15–22]. Sequencing the genomes of P. larvae phage is important so as to
identify P. larvae phage proteins and their function, uncover the mechanisms by which the
phages lyse P. larvae or enter lysogeny, and identify potentially dangerous or novel phage
proteins. For example, a putative toxin found in four phage genomes has been identified
as contributing to the pathogenicity of the ERIC I strain [23]. Two comparative genomic
studies have classified sequenced P. larvae phages into clusters, assigned putative functions
to phage proteins, and identified conserved genes [24,25]. Genome length ranges from
35 kbp to 55 kbp, and the 49 phages are grouped into four clusters and two singletons based
on average nucleotide sequence identity (ANI) [22,25]. All sequenced P. larvae phages are
temperate [22,25]. Roughly half of P. larvae phage proteins have putative function [25].
All sequenced P. larvae phages encode a N-acetylmuramoyl-L-alanine amidase that they
use to pierce their host’s peptidoglycan cell wall [22,25]. Three studies have focused on
the N-acetylmuramoyl-L-alanine amidase [26–28]; in one of these studies the amidase
was successfully used to rescue honeybee larvae infected with P. larvae [27]. The reader is
referred to ref. 29 for a review of P. larvae phages [29].
Despite the increase in information on P. larvae and the phages that infect them, no
study has yet investigated the existence or distribution of clustered regularly interspaced
short palindromic repeats (CRISPR) spacer sequences in P. larvae and P. larvae phages.
CRISPR is a bacterial and archaeal adaptive immune system that neutralizes invading
phages and plasmids by cutting foreign DNA at specific locations [30–32]. These specific
locations, called protospacers, are acquired from phage genomes during an infection and
introduced into the bacterial CRISPR locus as CRISPR spacer sequence [33]. Protospacers
are acquired from a region of the phage genome that is flanked by a protospacer adjacent
motif (PAM), a 2–5 base pair sequence, which varies in its sequence across bacteria and
archaea [34–37]. The PAM sequence differs from the palindromic repeat sequence in the
CRISPR locus of the host genome, eliminating the risk of self-targeting or self-cleaving of
the hosts’s genome [38]. In subsequent phage infections, the host can use its previously
acquired spacers as targets for complementary binding to the phage genomes; if such
binding occurs, the phage DNA is cleaved, thereby neutralizing the infection [39–44]. The
presence of phage spacer sequences in the P. larvae genome could thus compromise the
efficacy of phages as treatment agents.
In this study, we identified CRISPR spacer sequences in P. larvae genomes, searched
P. larvae phage genomes for spacer sequences, and assessed the distribution of CRISPR
spacer sequences in P. larvae strains and P. larvae phages. This study serves as a point
of reference for future experimental studies on the relationship between the presence of
spacers and phage lytic ability, as well as for comparative studies of spacer distribution in
other host–phage systems.
2. Materials and Methods
The complete genome sequences of nine P. larvae strains and 49 P. larvae phages were
obtained through a search of NCBI GenBank for complete genome sequences. CRISPR
spacer sequences were identified using the program CRISPRfinder (https://crispr.i2bc.paris-
saclay.fr/Server/ accessed on 12 February 2021) [45], with default settings. CRISPRfinder
outputs spacer information as “confirmed” or “questionable”; only “confirmed” spacers
were included in the analysis. “Questionable” spacers were also investigated but none were
found in the phage genomes. Prophages in the P. larvae strains were identified PHASTER,
with default settings [46,47].
To search the phage genomes for the spacer sequences, we developed a Python script
that searched the phage genomes for all spacer sequences identified with CRISPRfinder.
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A file containing the 49 sequenced phage genomes and a file containing the spacers were
compiled. Each spacer was searched for in each of the phage genomes. A match was made
if the spacer sequence was found in the phage genome sequence. The approach used here
was limited to exact string matches. The Python script then removed instance of spacers
found in more than one strain to establish the list of unique spacers. PAM sequences were
searched for by generating multiple alignments of the 10 bases upstream and downstream
of the spacer sequences and the PAM sequence was identified using WebLogo [48].
3. Results
3.1. Distribution of CRISPR Spacer Sequences in P. larvae Strains
The P. larvae strains used in this analysis, along with their NCBI accession numbers, are
listed in Table 1. Searching these P. larvae genomes with CRISPRfinder revealed 714 spacer
sequences across all nine sequenced P. larvae strains (Table 1). The full list of spacers
found in the nine sequenced P. larvae strains is given in Supplementary Table S1. Some
strains have duplicate spacers; thus the number of unique spacers in each strain is slightly
smaller. The distribution of spacers is highly uneven (Table 1), with strains SAG 10367
(ERIC II) and DSM 106052 (ERIC V) having more than 100 spacers, and strains ATCC 9545
(ERIC I), DSM 7030 (ERIC I), and DSM 25430 (ERIC II), fewer than 20. In general, the
epidemiologically important ERIC I and ERIC II strains (with the exception of SAG 10367)
have noticeably fewer spacers than the ERIC III-V strains. Though the ERIC I strains
ATCC 9545 and DSM 7030 have the same number of CRISPR arrays and spacers, they do
not share spacers. The number of CRISPR arrays ranges from one to seven, with most
strains having six to seven arrays, ranging in size from three to 30 spacers. Some spacers are
present in multiple P. larvae strains; their distribution is shown in Table 2. Approximately
two-thirds of spacers are found in only one P. larvae strain, while two spacers are found
in eight of nine P. larvae strains. The ERIC III strain LMG 16252, and the ERIC IV strains
ATCC 13537, CCM 38, and LMG 16247 are all closely related and generally share the same
spacers, which accounts for the 83 spacers found in four strains in Table 2.
Table 1. CRISPR array and spacer data for the P. larvae strains with a completely sequenced genome used in this study.









ATCC 9545 4 17 17 ERIC I CP019687
DSM 7030 4 17 17 ERIC I CP019651
DSM 25430 1 8 5 ERIC II CP003355
SAG 10367 7 169 159 ERIC II CP020557
LMG 16252 6 95 93 ERIC III CP019655
ATCC 13537 7 97 95 ERIC IV CP019794
CCM 38 7 97 95 ERIC IV CP020327
LMG 16247 7 98 96 ERIC IV CP019659
DSM 106052 6 116 111 ERIC V CP019717
Table 2. Frequency of occurrence of spacers in P. larvae strains.
1 Strain 2 Strains 3 Strains 4 Strains 5 Strains 6 Strains 8 Strains
No. of spacers found in 254 30 12 83 2 1 2
% of spacers found in 66.1% 7.8% 3.1% 21.6% 0.5% 0.25% 0.5%
The number of intact, incomplete, and questionable prophages in each P. larvae strain,
and the number of spacers in intact, incomplete, and questionable prophages is shown
in Table 3. No spacers were found in intact prophages; only three spacers were found in
incomplete prophages; and four in questionable prophages. Considering the number of
spacers and the number of prophages in P. larvae strains, the number of spacers in prophage
regions is extremely low.
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Table 3. Number of prophages in P. larvae strains and number of spacers located in prophage regions.
P. larvae Strain
No. of Prophages No. of Spacers Located in Prophages
Intact Questionable Incomplete Intact Questionable Incomplete
ATCC 9545 5 2 10 0 0 0
DSM 7030 5 1 12 0 0 0
DSM 25430 2 1 9 0 0 0
SAG 10367 5 7 12 0 0 1
LMG 16252 8 3 7 0 1 0
ATCC 13537 5 3 6 0 0 1
CCM 38 6 3 11 0 1 1
LMG 16247 4 5 8 0 2 0
DSM 106052 5 5 14 0 0 0
3.2. CRISPR Spacer Sequence Identification in P. larvae Phage Genomes
When spacers occurring in multiple strains are accounted for, there are 384 unique
spacers across all nine P. larvae strains. The 384 spacers were searched for in the 49 se-
quenced P. larvae phage genomes using a Python script, resulting in the identification
of 57 spacer sequences (i.e., protospacers) in the 49 phage genomes. The distribution of
the phages by number of protospacers is shown in Figure 1. About a third of sequenced
P. larvae phages do not contain any protospacers, about a third contain one protospacer, and
about a third contain more than one protospacer; two P. larvae phages contain a maximum
of four protospacer sequences.
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Figure 1. Distribution of P. larvae phages by number of unique protospacers.
After ac ounting for protospacer sequences found in more than one phage, a total of
18 unique protospacer sequences were identified in the phage genomes. The distribution
of these protospacers in P. larvae strains and P. larvae phages is shown in Figure 2. Phage
clusters and ERIC genotypes are shown in brackets on the right. The phages are grouped
by genomic clusters, based on hole-genome average nucleotide sequence identity ( I).
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The current classification of sequenced P. larvae phages consists of four clusters and
two singletons [22,25]. Clusters are named after a representative phage from each cluster.
The largest cluster is the Fern cluster (30 members), followed by the Halcyone cluster
(eight members), the Vegas (seven members), the Harrison cluster (two members), and
two singletons, Lily and API480. The distribution of protospacers juxtaposed with the
49*49 ANI matrix is included as Supplemental Figure S1.
As seen in Figure 2, with the exception of SAG 10367, the ERIC I and ERIC II strains
have noticeably fewer protospacers compared to the ERIC III–V strains (just as they have
fewer spacers in general, per Table 1). Strain ATCC 9545 does not contain any protospacers,
while DSM 7030 and DSM 25430 each contain only one protospacer, in both cases in phages
Harrison and Paisley. Strain SAG 10367 contains a total of eight unique protospacers from
30 phages that collectively span all four phage clusters and the singletons Lily and API 480.
SAG 10367 thus not only contains the most spacers and protospacers, but its protospacers
are also the most diverse in terms of the phages they are recruited from. The 18 unique
protospacers are generally unique to a P. larvae strain, the sole exception being protospacers
5, 6, 8, and 15, which are shared between the closely related ERIC III and ERIV IV strains
LMG 16252 ATCC 13537 CCM 38 and LMG 16247 (ATCC 13537 is missing protospacer 15).
Strain DSM 106052 (ERIC V, isolated in 2020) contains four unique protospacers not found
in other strains, and identified in three different phage clusters.
All phage clusters/singletons have a phage containing at least one of the 18 proto-
spacers, however the phages of the Vegas subcluster (phages Diane, Vadim, Vegas, Hayley)
and the Halcyone subcluster (phages Halcyone, Heath, Scottie, Unity) are lacking any pro-
tospacers. Phages LincolnB and Wanderer have the most protospacers (four), followed by
Harrison, Paisley, Lucielle, Lily, and Tripp, each with three protospacers. Of the phages that
contain multiple protospacers, these are roughly evenly split between seven phages whose
protospacers are found in multiple strains (phages LincolnB, Wanderer, Tripp, Lily, Har-
rison, Paisley, Kawika), and eight phages (phages Lucielle, Saudage, Genki, Gryphonian,
PBL1c, Ash, Ley, C7 Cdelta), whose protospacers are exclusively found in strain SAG 10367.
All but one of the 18 unique protospacer sequences are unique to one of the six phage
clusters/singletons, the sole exception being the SAG 10367 protospacer 7, which is found
in the Fern cluster and the singleton Lily. Protospacer 3, also from SAG 10367, is the most
widely distributed, found in 19 phages. Six protospacers (2, 8, 10, 11, 13, and 15) are unique
to one phage. Protopacers 1, 14, and 18 are unique to the very closely related phages
Harrison and Paisley (98% ANI); protospacers 5, 6, and 9 are unique to the very closely
related phages LincolnB and Wanderer (99% ANI); and protospacers 4 and 12 are unique to
the closely related phages Ash, Ley, and C7 Cdelta (all with <96% ANI to each other). Thus,
14 of the 18 protospacers are unique to either one phage or small groups of very closely
related phages.
Protospacer 3 is of particular interest due to its high frequency in the Fern cluster
and its location in the large terminase gene, which is highly conserved among cluster
members [25]. In spite of this, 11 of the 30 phages in the Fern cluster lack this protospacer.
This is the case with even very closely related phages: Phages Kiel007 and Redbud both
contain protospacer 3, but Rani does not, despite having >99% ANI with Kiel007 and Red-
bud (Supplemental Figure S1). Similarly, phage Xenia contains protospacer 3 while phage
Shelly does not, despite 99.5% ANI (Supplemental Figure S1). This is also the case with
protospacer 16, which is found in the conserved tail tape measure protein and is found in
phages Genki and Gryphonian, but not among the remaining four phages in the subcluster,
all of whom have ~99% ANI with Genki and Gryphonian (Supplemental Figure S1).
This evidence suggests the existence of one or more point mutations in the protospacer
sequence. We searched the genomes of Fern cluster phages that lacked protospacers 3, 7, 15,
and 16 for mutations at that location by aligning the protospacer sequences with the phage
genomes. Of the 11 Fern cluster phages not containing the exact sequence of protospacer 3,
ten of them were found to have a single point mutation in the protospacer region, while the
same region in phage BN12 differed by five nucleotides. All of the 26 Fern cluster phages
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that are missing protospacer 16 were found to have one or two point mutations in the
protospacer region. This was not the case for protospacers 7 and 15; Fern cluster phages
that are missing these protospacers have more than 10 nucleotides sequence differences in
the protospacer region.
The full list of the 18 unique protospacers, their length, the P. larvae strains, phages,
and phage genes they are found in, is shown in Table 4. Protospacer length ranges from
33 bp to 38 bp. Sixteen protospacers are located in coding regions; two are located in
intergenic regions (P. larvae phage genomes are 90–95% coding, [25]). Of the 16 protospacers
located in coding regions, eight are located in a gene with putative function, and eight in a
hypothetical gene (about half of P. larvae genes have putative function, [25]). Protospacer 3
is located in the large terminase gene (near the genome start), and protospacer 16 in the
tail tape measure gene; both genes are conserved in P. larvae phages [25]. Both of these
protospacers are found in the SAG 10367 strain (ERIC II). Nevertheless, no pattern is
discernible regarding which part of the phage genome the protospacers are recruited
from; protospacers are recruited in the front, middle, and rear of the phage genome, and
in genes of widely differing functions, as well as hypothetical proteins and intergenic
regions. For example, protospacer 11 is located between bases 72–105 in a hypothetical
gene in phage API 480, while protospacer 10 is located in a hypothetical gene at the tail
end (bases 51,647–51,683) of the genome of phage Tripp.
Table 4. Complete list of the 18 unique protospacer sequences found in P. larvae strains and phages.
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4. Discussion
This study establishes the existence of CRISPR spacer and protospacer sequences in
the genomes of sequenced strains of P. larvae and P. larvae phages. Searching the genomes
of nine P. larvae strains, we identified 384 unique spacer sequences. The number of spacers
per strain ranges from 7 to 169, which is similar to what has been observed in systems
such as Clostridium difficile (43–153 spacers per strain) [49], and Microcystis aeruginosa
(47–174 spacers per strain) [50]. Of importance is that the epidemiologically important
ERIC I strains ATCC 9545 and DSM 7030, and the ERIC II strain DSM 25340 contain
relatively few spacers (fewer than 20); presumably, AFB outbreaks caused by these or
related strains would be the most treatable with phages. In general, the ERIC I and ERIC II
strains contain an order of magnitude fewer spacers than the ERIC III–V strains, the sole
exception to this being the ERIC II strain SAG 10367, which contains the highest number of
spacers (169). It is known that CRISPR-Cas and horizontal gene transfer (HGT) oppose one
another; an increase in the frequency of one results in a decrease in the frequency of the
other. While the ERIC I strains are responsible for the majority of AFB outbreaks globally,
the ERIC III–V strains are vanishingly rare in the field and exist mostly in archived cultures;
they would thus presumably not experience as much HGT as the ERIC/II strains. Thus,
one possible explanation for the low frequency of spacers in the ERIC I strains is that these
strains downregulate CRISPR-Cas so as to facilitate acquisition of beneficial genes through
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HGT, whereas the ERIC III and ERIC IV strains would have less need for HGT. On the
other hand, the high number of spacers in the SAG 10367 strain implies that this strain
frequently comes under attack by phages, resulting in a large CRISPR array.
Approximately two-thirds (66%) of spacers are unique to a P. larvae strain, suggesting
distinct acquisition events. The main exception to this are the four genomically similar
ERIC III and IV strains, which largely share the same spacers due to common descent. By
comparison, the percentage of spacers that are unique to a strain ranges from as low as 9%
in Escherichia coli [51], to 75% for Vibrio cholerae [52], and 98% for the genus Thermus [53].
This suggests that the genomic diversity of P. larvae still remains to be fully sampled,
although not to the extent of non-culturable genera such as Thermus.
Of the 384 unique spacers, only 18 (~5%) were found in the 49 sequenced P. larvae
phage genomes as protospacers. This low coverage implies the existence of a large number
of novel undiscovered P. larvae phages, and that the bulk of the genetic landscape of P. larvae
phages remains to be discovered. By comparison, spacer coverage in C. difficile ranges
from 17% to 38%, with 162 unique protospacer sequences in 31 phages and prophage
genomes [49], while a study of the Vibrio cholerae system found 34% protospacer cover-
age [52]. On the other hand, the protospacer coverage of P. larvae phages is similar to what
has been reported for phages that infect less intensively studied hosts, such as Microcystis
aeruginosa (~4% coverage) and the genus Thermus (6% coverage) [50,53]. It has similarly
been proposed that the bulk of the genetic landscape of Thermus phages is undiscovered
for the same reason [53].
The distribution of the 18 protospacer sequences is uneven among P. larvae strains.
Strain SAG 10367 (ERIC II) contains eight unique protospacers from every phage cluster
or singleton, while strain ATCC 9545 (ERIC I) does not contain any protospacers and
strains DSM 7030 (ERIC I) and DSM 25430 (ERIC II) contain only one protospacer. The low
number of protospacers in three of the four ERIC I/II strains is encouraging for the use
of P. larvae phages to treat AFB. On the other hand, we should expect that AFB outbreaks
caused by strain SAG 10367, or strains related to it, to be the most difficult to treat with
phages. As with the spacers, most protospacers are unique to a P. larvae strain, the sole
exception being the protospacers shared between the ERIC III and ERIC IV strains due to
genetic relatedness. The fact that the majority of protospacers are unique to a particular
strain could explain why phages whose spacers are found in P. larvae are still able to lyse;
presumably, the strain of P. larvae they are able to lyse is a different strain from the one
containing their protospacer.
The protospacers are generally unique to individual phages as well, or else small
groups of very closely related phages; only four out of 18 protospacers do not fit this
pattern, and only one protospacer is found in two different phage clusters. Approximately
a third of the 49 sequenced P. larvae phages do not contain any protospacers sequences at all;
this is particularly encouraging for the use of phages to treat AFB, and such phages should
be preferred in phage cocktails used to treat infected beehives. No phages contain more
than four protospacers, which is a pretty low number. No pattern is discernible regarding
where the protospacers are recruited from in the phage genomes; protospacers are found
to originate from conserved genes, non-conserved genes, hypothetical proteins, as well as
intergenic regions. In contrast, all C. difficile phages were found to contain anywhere from
one to 16 protospacers, every C. difficile strain had at least one spacer from a phage, and the
spacers were noticeably recruited from conserved genes [49].
All sequenced P. larvae phages are strongly lytic in vitro [22,25], including those phages
that contain protospacer sequences identified in this study. For example, phages Fern and
Willow are among the most strongly lytic phages [13], but at least one P. larvae strain
(SAG 10367 of the ERIC II genotype) contains a protospacer sequence from their large
terminase protein. Similarly, three protospacer sequences were found in the genome of
phage Harrison, but this phage is also one of the most strongly lytic P. larvae phages [13].
Though the present data is sparse, there does not appear to be a negative correlation
between presence of protospacers in the phage genome and lytic ability. This also raises
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the question of whether P. larvae phages evade their host’s CRISPR defenses by means of
anti-CRISPR genes, particularly considering that currently half of P. larvae phage proteins
do not have putative function [25]. A preliminary search for anti-CRISPR genes using
AcrFinder did not yield results [54], but more work remains to be done in this area.
An additional mechanism by which P. larvae phages may evade CRISPR defense
systems is by point mutations in the protospacer or PAM sequence [55]. While 17 of the
18 protospacers appear to contain the putative -GA(A)- PAM sequence, two protospacers,
one located in the conserved large terminase gene (protospacer 3), and one located in the
conserved tail tape measure gene (protospacer 16), were found to have possible point
mutations at one or two locations in their protospacer sequence. This could be direct
evidence of the evolutionary arms race between P. larvae and their phages. However,
for phages to be able to escape CRISPR through mutation, the mutation has to be in the
seven-base “seed” sequence of the protospacer [56]; it is not yet known if the putative point
mutations we identified in the phage protospacers are indeed in the seed region.
The existence of CRISPR protospacers in a phage genome is an important consideration
when selecting phages for therapy, whether to treat AFB in honeybees or infections in other
organisms. A recent study by Philipson et al. describes a thorough workflow for selecting
phages for therapeutic applications [57]. To this workflow we would add the following:
use CRISPRFinder to identify spacer sequences in the host, then search the candidate
therapeutic phage for the spacer sequences; preference for therapeutic applications should
be given to those phages without protospacers in the host genome, or if that is not possible,
phages with protospacers from the same host. For example, under this scheme phage
Halcyone (no protospacers) would be a better choice for treating AFB than phage Saudage
(three protospacers from the same strain), which would in turn be a better choice than
phages Harrison and Paisley (three protospacers, each from a different strain of P. larvae).
As interest in P. larvae phages continues to grow, the number of sequenced P. larvae
strains and phages will grow as well. It will be interesting to obtain a more complete
picture of the genomic and CRISPR landscape of these phages, especially with regards
to the existence of anti-CRISPR genes in their genomes or other means they use to evade
host defenses. Additional future directions include testing experimentally the ability of P.
larvae phages to lyse P. larvae strains that contain protospacers from the phages, and more
detailed and comprehensive comparisons with the distribution of spacer and protospacer
sequences in other phage–host systems.
5. Conclusions
We present the first analysis of CRISPR spacer sequences identified in nine sequenced
P. larvae strains and 49 sequenced phages. Three of the four commercially important P. larvae
strains contain few spacers and protospacers, which is a positive finding for phage therapy
of AFB. Moreover, approximately a third of phages do not contain any protospacers, an
additional third contains only one protospacer, and the most protospacers in a phage
genome is four. Protospacers are thus relatively scarce in the P. larvae system, with only 5%
of spacers doubling as protospacers. This is an encouraging finding for phage therapy, and
also implies that much of the genomic landscape of P. larvae phages remains undiscovered.
Some phages appear to have point mutations in their protospacer sequences, possibly so as
to evade the hosts’ CRISPR defenses. The results of this study serve as a marker for future
studies on the CRISPR-Cas system in P. larvae as well as in other host–phage systems.
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